All insiders
LM
Lappe Mark
CEOPrimarily INBX
100% buying0% selling
Total Trades
16
16 buys · 0 sells
Total Bought
$4.49M
Total Sold
$0
Companies
1
Buy Win Rate
38%
16 buys priced
Avg Buy Return*
-8.23%
Best buy (vs current price)
INBX — bought $205.89K at $84.07, +4.5% since (Oct 14, 2026)
Active
Sep 8, 2026 → Oct 14, 2026
Trade Volume by Year
Buy Sell
Top Traded Sectors
Biological Products, (No Diagnostic Substances)16
Most-Traded Stocks
 INBXInhibrx Biosciences, Inc. | 16 | 16B / 0S | $4.49M |
Trade History
| Oct 14, 2026 | INBX | BUY | 2,449 | $84.07 | $205.89K | +4.5% |
| Oct 14, 2026 | INBX | BUY | 100 | $85.76 | $8.58K | +2.4% |
| Oct 14, 2026 | INBX | BUY | 100 | $85.76 | $8.58K | +2.4% |
| Oct 14, 2026 | INBX | BUY | 2,451 | $85.00 | $208.33K | +3.3% |
| Oct 14, 2026 | INBX | BUY | 2,470 | $84.07 | $207.65K | +4.5% |
| Oct 14, 2026 | INBX | BUY | 2,470 | $85.00 | $209.95K | +3.3% |
| Sep 28, 2026 | INBX | BUY | 1,500 | $98.88 | $148.32K | -11.2% |
| Sep 28, 2026 | INBX | BUY | 3,000 | $101.70 | $305.11K | -13.6% |
| Sep 25, 2026 | INBX | BUY | 3,324 | $98.87 | $328.63K | -11.2% |
| Sep 25, 2026 | INBX | BUY | 2,176 | $99.60 | $216.73K | -11.8% |
| Sep 8, 2026 | INBX | BUY | 5,895 | $99.29 | $585.34K | -11.5% |
| Sep 8, 2026 | INBX | BUY | 6,605 | $100.64 | $664.72K | -12.7% |
| Sep 8, 2026 | INBX | BUY | 1,100 | $107.12 | $117.84K | -18.0% |
| Sep 8, 2026 | INBX | BUY | 500 | $108.23 | $54.12K | -18.8% |
| Sep 8, 2026 | INBX | BUY | 1,219 | $111.88 | $136.38K | -21.5% |
| Sep 8, 2026 | INBX | BUY | 9,681 | $112.28 | $1.09M | -21.8% |
*Return = current share price vs the insider’s purchase price (buys only). Not the insider’s realized return. Informational only — not investment advice.